?. A/R CDM ?????? - ???
| Afficher les résultats avec :
??????????? ????????????? - ?????... ????????. 1 .???????. ???????? M.????????????. ??????????????????????. ???????????????? ... ???????????????????????????111??????????????. ?????????????????????????????. ??????????????? ... ??3????????????????? ??????????????????????? 27 ????????? 56%?????????????????????. ????????????????????????? ... ???????????? ?????????? ? ?????ICT ...??????????? 91.47%??????????. ??????????? ... ????????????????????. 80.4. ????????????? ... ???????9????????????? - ?????????????????????????????. ????????????? ... ???????????????. ?2023?8?18???????? ? ... Trusted Web ?????????????????URL ? TD ???. *. ??? QR ???. ??? App ?????? QR ... ????????. ????????????????????????? ... ????????????? - ??????????????????????9???????????????????. ????????????????????? ? ? 8?31??????7? ... Efficacy of Muscle Exercise in Patients with Muscular DystrophyMyotonic dystrophy type 1 is a neuromuscular disorder affecting multiple organ systems and is characterized by a variety of clinical ... Dosage effect of multiple genes accounts for multisystem ... - bioRxivDM1 is an uncommon cause of hypoxia due to weakness of the respiratory muscles leading to alveolar hypoventilation. Key physical examination ... Gastrointestinal manifestations in myotonic muscular dystrophy - ARPICell and animal models of DM1 have been crucial to providing insight into disease mechanisms and to revealing new therapeutic targets. Protocole National de Diagnostic et de Soins (PNDS) Dystrophie ...Recent achievements carried out on lipid nanoparticles enabling gene therapy with the approval of treatment for rare disease as Onpattro® and ... Molecular Therapies for Myotonic Dystrophy Type 1 - CNR IrisSince a curative treatment for DM1 is not yet available, patient management also requires frequent screening for possible disease complications.
Autres Cours:
